Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Source: S&P Dow Jones Indices; Chart: Naema Ahmed/Axios

A slew of companies put stock buyback plans on ice at the onset of the pandemic. Now some of them are beginning put share repurchases back on the table.

Why it matters: The ramping up of stock buybacks is a sign that swaths of corporate America feel confident enough to return to some sense of normalcy, even as millions of Americans are still dealing with the harsh fallout from the coronavirus-hit economy.

The latest: Intel said last week it would resume the previously announced $20 billion stock buyback plan that it put on ice when the pandemic hit. The company said "repurchases are prudent at this time, given the strength of the company's balance sheet," per its SEC filing.

  • Auto parts retailer O'Reilly Automotive restarted its share repurchase program in May after evaluating "business conditions and liquidity," executives said on an analyst call last month.
  • Agilent, which manufactures lab equipment, also said it would restart its regular pattern of buybacks. "We felt for some time that [fiscal] Q3 ... would be the toughest quarter for us for the year. We’re through that now," CEO Mike McMullen said to analysts.
  • A Barclays analyst predicts Honeywell is among manufacturers that will likely resume or ramp up stock buyback programs "as early as the current quarter," Bloomberg notes.

Yes, but: "The companies that are doing buybacks now have the money," Howard Silverblatt, senior index analyst at S&P Dow Jones Indices, tells Axios.

  • Companies in industries completely battered by the coronavirus — like airlines — are still holding off on buying back stock, Silverblatt notes.
  • Others that are sitting on fatter cash piles may be holding off in case business takes another turn for the worse.

By the numbers: S&P 500 companies spent nearly $86 billion dollars on stock buybacks so far this quarter, by Silverblatt's count — a marked slowdown from the $165 billion companies spent on repurchases this time last year.

The bottom line: Companies halted stock buybacks when the pandemic presented unprecedented uncertainty. The return of buybacks mean some think that era of uncertainty is over, even though the pandemic still poses great challenges to the U.S. economy.

Go deeper

Dow hits 30,000 for the first time

A trader outside the New York Stock Exchange in early November. (Photo: Angela Weiss/AFP via Getty Images)

The Dow Jones Industrial Average traded above 30,000 for the first time ever on Tuesday.

Between the lines: The milestone is symbolic — the Dow hitting 30,001, for instance, is no less significant. However, it underscores the stock market's meteoric rebound from the onset of the coronavirus pandemic: just 8 months ago, the Dow traded below 19,000.

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Vaccines: U.S. ahead of pace on vaccines.
  2. Health: Lessons for trapping the next pandemic.
  3. Tech: "Fludemic" model accurately maps COVID hotspotsVirtual doctor's visits and digital health tools take off.
  4. Politics: Harris breaks tie as Senate proceeds with lengthy debate on COVID relief bill — Republican governor of West Virginia says there's no plan to lift mask mandate.
  5. World: Canada vaccine panel recommends 4 months between doses — In AstraZeneca spat, EU fights hard for a vaccine its hardly using.
Dave Lawler, author of World
1 hour ago - World

In AstraZeneca spat, EU fights hard for a vaccine it's hardly using

Macron, Merkel and European Council President Charles Michel (R) at a summit in October. Photo: Yves Herman/Pool/AFP via Getty

Italy on Thursday blocked the export of 250,000 AstraZeneca doses to Australia, becoming the first EU country to exercise an export ban due to a vaccine shortfall in the bloc.

Why it matters: The controversial step exposes multiple major challenges to distributing vaccines — even among the world’s richest countries.